It is widely recognized that the way we approach the understanding, diagnosis, and treatment of disease is rapidly changing. Emerging technologies in genomics, epigenomics, proteomics, nanotechnology, molecular diagnostics and imaging are enabling this rapid revolution. Consequently, there is a growing need to transform from a reactive, one-size-fits all approach to a more personalized system of predictive, preventive, and precision healthcare that is tailored to a population or an individual.
The overall goal of the CIHR Personalized Medicine Signature Initiative is to enhance health outcomes through patient stratification approaches by integrating evidence-based medicine and precision diagnostics into clinical practice. This initiative offers hope to many areas of health including cancer, metabolic and cardiovascular diseases, rare diseases, and infectious diseases, among others.
- Date modified: